Results 11 to 20 of about 1,153,912 (357)

Difficult case of differential diagnosis of partial lung atelectasis. Case report

open access: yesТерапевтический архив, 2023
In December 2018 the patient over 60 years old sought medical help with complaints of persistent cough. Based on computed tomography data there were identified the sings (symptoms) of right lung lower lobe atelectasis.
Olga M. Gordeeva   +6 more
doaj   +1 more source

Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis

open access: yesJournal of Immunology Research, 2022
Objective. Multidrug-resistant tuberculosis (MDR-TB) causes persistent infection and challenges tuberculosis control worldwide. T cell-mediated immunity plays a critical role in controlling Mycobacterium tuberculosis (Mtb) infection, and therefore ...
Peijun Tang   +17 more
doaj   +1 more source

Tuberculosis and the Heart [PDF]

open access: yesJournal of the American Heart Association, 2021
Abstract Acquired tuberculosis continues to be a challenge worldwide. Although tuberculosis has been considered a global public health emergency, it remains poorly controlled in many countries. Despite being primarily a pulmonary disease, tuberculosis could involve the heart.
Lopez-Lopez, José   +10 more
openaire   +7 more sources

Tuberculosis [PDF]

open access: yesEuropean Respiratory Review, 2014
This article reviews the published literature on tuberculosis from September 2012 to August 2013 and describes important advances in tuberculosis epidemiology, microbiology, pathology, clinical pharmacology, genetics, treatment and prevention.
openaire   +5 more sources

Possibilities of non-invasive diagnosis of fibrotic phenotype of interstitial lung diseases

open access: yesТерапевтический архив, 2023
Progressive pulmonary fibrosis is a major problem in respiratory medicine. Currently, there are no reliable biomarkers for early diagnosis of progressive pulmonary fibrosis, which leads to delayed diagnosis. Aim.
Evgeniy I. Shchepikhin   +5 more
doaj   +1 more source

Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette–Guérin vaccination

open access: yesScientific Reports, 2021
Universal Bacillus Calmette–Guérin (BCG) vaccination is recommended in countries with high tuberculosis (TB) burden. Nevertheless, several countries have ceased universal BCG vaccination over the past 40 years, with scarce comparative epidemiological ...
Sayori Kobayashi   +4 more
doaj   +1 more source

Adolescent tuberculosis [PDF]

open access: yesThe Lancet Child & Adolescent Health, 2020
Adolescence is characterised by a substantial increase in the incidence of tuberculosis, a known fact since the early 20th century. Most of the world's adolescents live in low-income and middle-income countries where tuberculosis remains common, and where they comprise a quarter of the population.
Snow, K.J.   +12 more
openaire   +6 more sources

Successful treatment of advanced tuberculosis of a single lung with staged correction of post-pneumonectomy syndrome

open access: yesВестник хирургии имени И.И. Грекова, 2021
An observation from practice is given – surgical treatment of a patient with advanced tuberculosis of a single lung and a pronounced lung displacement. Patient A., 47 years old, after 3 months from the left pneumonectomy for fibrocavernous tuberculosis ...
R. V. Tarasov   +5 more
doaj   +1 more source

TUBERCULOSIS [PDF]

open access: yesSouthern Medical Journal, 1893
Approximately one-third of the world population is infected with Mycobacterium tuberculosis, the organism that causes tuberculosis (TB). After a brief resurgence beginning in the mid-1980s, the incidence of TB is once again declining in the United States.
openaire   +4 more sources

Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

open access: yesBMC Public Health, 2021
Background BPaL, a 6 month oral regimen composed of bedaquiline, pretomanid, and linezolid for treating extensively drug-resistant tuberculosis (XDR-TB) is a potential alternative for at least 20 months of individualized treatment regimens (ITR). The ITR
S. E. J. van de Berg   +20 more
doaj   +1 more source

Home - About - Disclaimer - Privacy